A role for the class A penicillin-binding protein PonA2 in the survival of Mycobacterium smegmatis under conditions of nonreplication.
Class A penicillin-binding proteins (PBPs) are large, bifunctional proteins that are responsible for glycan chain assembly and peptide cross-linking of bacterial peptidoglycan. Bacteria in the genus Mycobacterium have been reported to have only two class A PBPs, PonA1 and PonA2, that are encoded in their genomes. We report here that the genomes of Mycobacterium smegmatis and other soil mycobacteria contain an additional gene encoding a third class A penicillin-binding protein, PonA3, which is a paralog of PonA2. Both the PonA2 and PonA3 proteins contain a penicillin-binding protein and serine/threonine protein kinase-associated (PASTA) domain that we propose may be involved in sensing the cell cycle and a C-terminal proline-rich region (PRR) that may have a role in protein-protein or protein-carbohydrate interactions. We show here that an M. smegmatis Delta ponA2 mutant has an unusual antibiotic susceptibility profile, exhibits a spherical morphology and an altered cell surface in stationary phase, and is defective for stationary-phase survival and recovery from anaerobic culture. In contrast, a Delta ponA3 mutant has no discernible phenotype under laboratory conditions. We demonstrate that PonA2 and PonA3 can bind penicillin and that PonA3 can partially substitute for PonA2 when ponA3 is expressed from a constitutive promoter on a multicopy plasmid. Our studies suggest that PonA2 is involved in adaptation to periods of nonreplication in response to starvation or anaerobiosis and that PonA3 may have a similar role. However, the regulation of PonA3 is likely different, suggesting that its importance could be related to stresses encountered in the environmental niches occupied by M. smegmatis and other soil-dwelling mycobacteria.
Patru
Maria-Magdalena
MM
University of Rochester Medical Center, Department of Microbiology and Immunology, 601 Elmwood Ave., Rochester, NY 14642, USA.
Pavelka
Martin S
MS
D000595:Amino Acid Sequence; D000693:Anaerobiosis; D015964:Gene Expression Regulation, Bacterial / Q000502:physiology; D008969:Molecular Sequence Data; D009154:Mutation; D020102:Mycobacterium smegmatis / Q000235:genetics / Q000378:metabolism*; D010101:Oxygen Consumption; D046915:Penicillin-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D013997:Time Factors
D046915:Penicillin-Binding Proteins
J Bacteriol. 2009 Jan;191(2):625-31
19011036
Bacteriol Rev. 1972 Dec;36(4):407-77
4568761
Bacteriol Rev. 1968 Dec;32(4 Pt 2):425-64
4884715
Nat Med. 2008 Aug;14(8):849-54
18641659
J Bacteriol. 1999 Aug;181(16):4780-9
10438745
J Bacteriol. 2006 Nov;188(21):7470-6
16936012
J Bacteriol. 1992 Oct;174(20):6508-17
1400203
Biochim Biophys Acta. 2005 Feb 14;1747(1):57-66
15680239
J Biol Chem. 2000 Jun 2;275(22):16490-6
10748168
Infect Immun. 1985 Feb;47(2):457-64
3967924
Microbiology (Reading). 2005 Feb;151(Pt 2):521-532
15699201
Microbiology (Reading). 2006 Feb;152(Pt 2):493-504
16436437
Biochem J. 2000 Aug 15;350 Pt 1:75-80
10926828
J Bacteriol. 1996 Nov;178(22):6496-507
8932306
J Bacteriol. 2008 Jun;190(12):4360-6
18408028
Antimicrob Agents Chemother. 1999 Dec;43(12):3011-3
10582900
Annu Rev Biochem. 1995;64:29-63
7574484
Microbiology (Reading). 2006 Jun;152(Pt 6):1789-1797
16735741
J Biol Chem. 2007 May 4;282(18):13151-9
17311917
Antimicrob Agents Chemother. 1999 May;43(5):1124-8
10223924
Pure Appl Chem. 1971;25(1):135-65
4942192
Tuberculosis (Edinb). 2003;83(4):261-9
12906837
Nature. 1991 Jun 6;351(6326):456-60
1904554
Biochem J. 1994 Jan 15;297 ( Pt 2):249-60
8297327
J Bacteriol. 2005 Apr;187(7):2341-7
15774877
Science. 2009 Sep 18;325(5947):1552-5
19762646
Curr Microbiol. 2002 Feb;44(2):125-31
11815857
J Bacteriol. 2005 Mar;187(6):1892-900
15743935
J Exp Med. 2009 Aug 3;206(8):1709-16
19581406
FEMS Microbiol Lett. 1995 Jan 1;125(1):95-100
7867925
Tuberculosis (Edinb). 2004;84(1-2):29-44
14670344
Biochem J. 2002 Feb 1;361(Pt 3):635-9
11802794
Microbiol Mol Biol Rev. 2002 Dec;66(4):702-38, table of contents
12456788
J Antimicrob Chemother. 2009 Mar;63(3):451-7
19109339
Biochemistry. 1974 Aug 13;13(17):3471-6
4210702
Nature. 1998 Jun 11;393(6685):537-44
9634230
Z Immunitatsforsch Exp Klin Immunol. 1975 Jul;149(2-4):118-25
126548
J Mol Biol. 2000 Jun 2;299(2):477-85
10860753
Trends Biochem Sci. 1999 Apr;24(4):132-3
10322416
J Bacteriol. 1996 Jan;178(1):273-9
8550428
Microb Ecol. 2005 Jul;50(1):110-9
16132428
FEBS Lett. 1970 Jan 15;6(1):55-57
11947336
FEMS Microbiol Lett. 2004 Sep 1;238(1):9-15
15336396
J Bacteriol. 1998 May;180(9):2459-67
9573199
Tuberculosis (Edinb). 2003;83(1-3):91-7
12758196
Microbiology (Reading). 2000 Sep;146 ( Pt 9):2209-2217
10974108
FASEB J. 2000 Feb;14(2):231-41
10657980
J Biol Chem. 2006 Jan 6;281(1):549-58
16257954
Biochim Biophys Acta. 1970 Jun;208(3):444-51
4990198
J Biol Chem. 2005 Nov 18;280(46):38146-52
16144833
Biken J. 1970 Dec;13(4):249-75
4994913
Protein Eng Des Sel. 2004 Feb;17(2):175-82
15047914
J Bacteriol. 2005 Apr;187(8):2747-57
15805521
Mol Microbiol. 1990 Nov;4(11):1911-9
2082148
Microb Ecol. 2004 Aug;48(2):230-8
15107954
Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):95-8
776875
J Biol Chem. 2005 Jan 7;280(1):326-33
15522883
Mol Microbiol. 1997 Feb;23(4):693-704
9157241
Int J Syst Evol Microbiol. 2002 Nov;52(Pt 6):1997-2002
12508859
Mol Microbiol. 2002 Nov;46(3):623-35
12410821
Infect Immun. 1982 Sep;37(3):1042-9
6813266
Microbiol Mol Biol Rev. 1998 Dec;62(4):1079-93
9841666
J Bacteriol. 1996 Mar;178(6):1707-11
8626300
J Biol Chem. 2002 Sep 27;277(39):35801-7
12077139
Trends Biochem Sci. 2002 Sep;27(9):438
12217513
Mol Microbiol. 2007 Nov;66(3):658-68
17919286